Vyne Therapeutics Inc (VYNE) — Strategic Asset Allocation Index
Vyne Therapeutics Inc (VYNE) has a Strategic Asset Allocation Index of 0.3% as of September 2022. Strategic assets (PP&E of $127.00K plus long-term investments of $-) total $127.00K, measured against net assets of $40.07 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Vyne Therapeutics Inc (VYNE) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Vyne Therapeutics Inc Strategic Asset Allocation Index (2018–2021)
This chart shows how Vyne Therapeutics Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2018 to 2021. As of September 2022, the index stands at 0.3%, representing strategic assets of $127.00K against net assets of $40.07 Million USD. For live market cap and overall valuation, see how much is Vyne Therapeutics Inc worth.
Annual Strategic Asset Allocation Index for Vyne Therapeutics Inc (2018–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Vyne Therapeutics Inc from 2018 to 2021, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Vyne Therapeutics Inc book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.7% | $354.00K | $354.00K | $- | $48.64 Million | ▼ -5.0 pp |
| 2020 | 5.7% | $2.14 Million | $2.14 Million | $- | $37.49 Million | ▼ -1.0 pp |
| 2019 | 6.7% | $4.58 Million | $4.58 Million | $- | $68.51 Million | ▲ +5.0 pp |
| 2018 | 1.7% | $2.23 Million | $2.23 Million | $0.00 | $130.38 Million | — |